Pfizer Provides Update on US FDA Review of Abrocitinib and XELJANZ® Filings,

The FDA cited its ongoing review of Pfizer’s post-marketing safety study, ORAL … XELJANZ has been studied in more than 50 clinical trials worldwide, …, The FDA cited its ongoing review of Pfizer’s post-marketing safety study, ORAL … XELJANZ has been studied in more than 50 clinical trials worldwide, …, Read More

Scroll to Top